Taken together, these results suggested that BAFF expression contributed to the CRSwNP recurrence and serum BAFF might serve as a potential biomarker for predicting postoperative recurrence in CRSwNP patients. The gene discussed is TNFSF13B; the disease is chronic rhinosinusitis with nasal polyps.